# Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid Overload

> **NCT01508260** · NA · WITHDRAWN · sponsor: **M.D. Anderson Cancer Center**

## Conditions studied

- Leukemia

## Interventions

- **PROCEDURE:** Aquapheresis
- **DRUG:** Furosemide

## Key facts

- **NCT ID:** NCT01508260
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-03
- **Primary completion:** 2018-03
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2013-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01508260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01508260, "Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid Overload". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01508260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*